Article | Open | Published:

A sensitive and rapid immunoassay for Mycoplasma pneumoniae in children with pneumonia based on single-walled carbon nanotubes

Scientific Reportsvolume 7, Article number: 16442 (2017) | Download Citation

Abstract

Mycoplasma pneumoniae(MP) is a leading pathogen of respiratory infection, especially community-acquired pneumonia (CAP), in children worldwide. However, its diagnosis is frequently ineffective because bacterial culture and serology test are usually positive 1–2 weeks or more after the disease onset. To achieve a better detection efficiency, the single-walled carbon nanotubes(SWCNT) were coupled with the colloidal gold-monoclonal antibody immunochromatographic strips(CGIC). Interestingly, the SWCNT/CGIC assay allowed MP identification, with a detection limit of 1 × 102 copies/ml. Using referenced throat swabs of 97 MP and 40 non-MP cases, the assay yielded 72.2% sensitivity, 100.0% specificity, 100.0% positive predictive value (PPV), 59.7% negative predictive value (NPV). In summary, our assay was far more effective than any conventional methods for the diagnosis of acute MP. The ease of use, rapid and stability further enhance its feasibility for clinical use on-site.

Introduction

Mycoplasma pneumoniae (MP) is a respiratory bacterial pathogen causing upper and lower respiratory disease in humans of all ages. It is considered a major cause of pneumonia, especially in children of school age and in some cases can result in serious extrapulmonary sequelae1,2. MP was detected in 30% of pediatric community-acquired pneumonia (CAP), and in over 50% among children aged 5 years or older3. These infections are difficult to discern from other causes of pneumonia based on examination, symptoms, or chest X-ray findings, and treatment with routinely used β-lactam antibiotics is ineffective against such organisms that lack a cell wall, laboratory identification of the etiology is critical to establish the correct course of treatment4,5. There are no specific clinical, epidemiological, or laboratory findings that allow a definite diagnosis of Mycoplasma infection early in the clinical course. Thus, isolation of MP remains the gold standard as a diagnostic procedure for this infection6. Cultures of a throat swab or sputum specimens may show MP, but growth is rarely detected earlier than 1 week after the start of culture. Seroconversion or a 4-fold increase in the MP antibody titer on examination of acute and convalescent sera is also diagnostic. However, the confirmation of MP infection by such methods is generally too slow to be of practical use7. During the past years, many analytical techniques for quantitative determination of MP have been studied, including Enzyme-linked immunosorbent assays (ELISA) and Polymerase chain reactionanalysis (PCR), which are sensitive but typically require skilled operators, complex sample pretreatments, expensive instruments, and time-consuming, thus impairing their applications in detection of MP8,9.

Carbon nanomaterials(CNMs) have shown great potential in biomedical applications, mainly due to their unique chemical and physical properties10,11. Carbon nanotubes is one of the most widely used CNMs due to their physical and chemical stability as well as their high surface area-to-weight ratio12,13. In this study, we developed an ultrasensitive antigen assay based on the single-walled carbon nanotubes(SWCNT) coupled with the colloidal gold-monoclonal antibody immunochromatographic strips (CGIC). Then, a large sample size study was conducted to assess the clinical diagnostic value of the newly developed strip, in comparison with that of a commercial real-time PCR assay.

Results

Conjugation optimization and characterization of antibody-gold/SWCNT

The TEM images showed well-dispersed colloidal gold particles(Fig. 1A) and SWCNT (Fig. 1B). The average diameter of the colloidal gold particles was 28.95 ± 9.37 nm, which provided a good basis for preparation of CGIC. To stabilize colloidal gold particles, the optimum pH of antibody adsorption was determined to be 9.0. At this pH, 8 μg/mL capture antibody was confirmed to be the minimum amount for stabilizing colloidal gold solution. To ensure that enough antibody was used to conjugate with the gold particles and stabilize the colloidal gold, 10 μg/mL capture antibody was determined to be the optimum cencentration of monoantibody for the conjugation(Fig. 1C). The antibody-gold conjugates were adsorbed onto SWCNT and imaged using TEM (Fig. 1D). The TEM results were confirmed by UV/Vis spectra. According to the UV/Vis spectra of the colloidal gold and antibody-gold/SWCNT, there was a shift of peaks by antibody and SWCNT treatment. The peak at 529 nm of the colloidal gold curve was due to the surface resonance of colloidal gold particles. Added with the antibody and SWCNT, the surface resonance band shifted a little (Fig. 1E,F).

Figure 1
Figure 1

Characterization of antibody-gold/SWCNT. The TEM images of gold nanoparticle (A), SWCNT (B), antibody-gold conjugate (C) and antibody-gold/SWCNT (D). Yellow arrow:SWCNT, red arrow:gold nanoparticle. UV/Vis spectra of colloidal gold (E) and the antibody-gold/SWCNT conjugate (F).

Mycoplasma pneumoniae detection in the SWCNT/CGIC strip

The principle of the single-walled carbon nanotube/colloidal gold-based immunochromatographic(SWCNT/CGIC) strip for Mycoplasma pneumoniae detection is illustrated in Fig. 2A. As shown in Fig. 2B, MP presence in a sample resulted in both the test and control lines being positive. A sample without MP displayed only a positive control line. To confirm the detection capacity of the colloidal gold assay, P1 genes of standard subtypes I(M129) and II(FH) Mycoplasma pneumoniae strains and one isolate of MP obtained from a patient were tested. The results showed that FH and M129 strains and isolates were positive in the SWCNT/CGIC assay (Fig. 2C).

Figure 2
Figure 2

(A) Scheme of the SWCNT based immunochromatographic strips for MP detection. (B) SWCNT/CGIC strip setup is representative of a negative sample (left), and a positive sample(right). (C) FH (I,1 × 102 copies/mL), M129 (II,1 × 102 copies/mL) and isolates of MP (III, 1 × 102 copies/mL) test results in the colloidal gold assays. IV:Negative control.

Comparison of SWCNT/CGIC strip and CGIC strip without SWCNT

As shown in Fig. 3, the sample was recorded as positive if two clear red lines were observed. Different concentrations of MP samples (FH strain) were dropped onto the prepared strips. 1 × 103 and 1 × 102 copies/mL of MP samples(Fig. 3A,C) gave positive results using SWCNT/CGIC strip, 1 × 103 copies/mL of MP sample(Fig. 3B) also gave positive result using CGIC strip without SWCNT, while 1 × 102 copies/mL of MP sample(Fig. 3D) gave negative result using CGIC strip without SWCNT. These results showed that the SWCNT/CGIC strip had a higher sensitivity than the the conventional testing.

Figure 3
Figure 3

Mycoplasma pneumoniae detection. (B) Comparison the SWCNT/CGIC strip (A,C) with CGIC strip (B,D without SWCNT). (A) and (B) 1 × 103 copies/mL, (C) and (D) 1 × 102 copies/mL.

Specificity, sensitivity and stability of the SWCNT/CGIC strip for Mycoplasma pneumoniae

To confirm the specificity of the strip,various conventional or atypical pneumonia pathogens were prepared by sample buffer, each pathogen at a concentration of 1 × 105 copies/ml: Mycoplasma pneumoniae, Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus, Escherichia coli, Klebsiella Pneumoniae, Pseudomonas aeruginosa, Enterobacter cloacae, Staphylococcus epidermidis, Acinetobacter baumannii, Chlamydia pneumoniae, adenovirus, respiratory syncytial virus, parainfluenza virus, influenza virus, human cytomegalovirus, human metapneumovirus and enteroviruses were assessed in 3 independent experiments. Our results showed that Mycoplasma pneumoniae was identified correctly by the assay with no cross-reactions found between MP and other pathogens (Data not shown).

To assess the sensitivity of the SWCNT/CGIC strip, standard Mycoplasma pneumoniae was quantified by real-time PCR and submitted to serial dilutions to obtain 101 to 106 copies/ml. Different concentrations of standard Mycoplasma pneumoniae were tested by the SWCNT/CGIC strip. As shown in Fig. 4A, MP with concentrations of 1 × 102–1 × 106copies/ml were positive in the assay (5 independent experiments). MP was not detected at 1 × 101 copies/ml. The intensity of red density on T lines was determined by using colloidal gold reading system. This result of reader showed that the detection limit of the SWCNT/CGIC strip for MP was 1 × 102 copies/ml (Fig. 4B). To evaluate the stability of immunochromatographic strips during storage, several of the immunochromatographic strips were stored for 3, 6, 12 and 18 months at room tempreature. The immunochromatographic strips left at room temperature for 12 months were not altered in terms of MP detection activity, whereas continual storage at room temperature for 18 months led to a reduction insensitivity.This demonstrated that the strips were stable for at least 12 months at room temperature(Data not shown).

Figure 4
Figure 4

Sensitivity of the SWCNT/CGIC assay. (A) (a) 1 × 106copies/ml; (b) 1 × 105 copies/ml; (c) 1 × 104 copies/ml; (d) 1 × 103 copies/ml; (e) 1 × 102 copies/ml; (f) 1 × 101 copies/ml; (g) Negative control. (B) The intensity of red density on T lines was determined by using colloidal gold reading system. *P > 0.05; & P < 0.05; § P < 0.01 vs. Negative control (g).

Effect of saliva, drugs on the SWCNT/CGIC strip

To confirm the anti-interference ability of the strip, saliva and drugs of various concentrations were prepared by sample buffer. The results showed that at reasonable saliva(<30%, V:V) or drug(<5 mg/ml) concentrations, there was no effect on the detection of the SWCNT/CGIC strip for Mycoplasma pneumoniae (Fig. 5).

Figure 5
Figure 5

Effect of saliva, drugs on the SWCNT/CGIC strip. (A) Saliva (B) Azithromycin (C) Erythromycin (*P > 0.05; & P < 0.05 vs. Control group; MP = 1 × 102 copies/mL,time = 15 mins).

Clinical specimen data

Among all the patients of MP group and Negative control group, 137 received MP SWCNT/CGIC assay. The results are shown in Table 1. PPV of SWCNT/CGIC assay was 100% and NPV was 59.7%. We concluded that the SWCNT/CGIC assay constructed by us had a high probability for confirming a diagnosis of Mycoplasma pneumoniae pneumonia and for guiding antibiotic choice for patients not yet treated.

Table 1 Sensitivity, specificity, and positive and negative predictive values of the SWCNT/CGIC assay for clinical specimens.

Discussion

Mycoplasma pneumoniae (MP) is a common pathogen of primary atypical pneumonia and other respiratory infectious diseases14,15. In addition, it is one of the most important agents of acute respiratory infections in children between the ages of 5 and 15 years. At present15,16, several methods are available for the diagnosis of infection, including culture, serological tests, and real time PCR techniques17,18,19. Real-time PCR and serological tests are currently used to diagnose MP clinically in China. But time-consuming and complicated protocols restrict their clinical application. Our SWCNT/CGIC assay offers a sensitive and specific tool for rapid and simultaneous detection of MP.

Colloidal gold-based immunochromatographic assay has been confirmed to be a rapid and sensitive method for serological surveillance and detection of bacterial pathogens in the field20. In this study, we applied SWCNT/CGIC assay to detect MP by targeting the specific P1 antigen. The membrane protein P1 is thought to have a major receptor-binding role in MP21. Clinical MP strains can be divided into two types (I and II) according to their P1 gene variants22,23. The SWCNT/CGIC assay has high capacity to detect both types of MP. MP detection could be completed in 10 minutes by using our method, while real-time PCR requires 2 to 4 hours, and culture usually takes 21 days or more19,24.

This work clearly reveals that single-walled carbon nanotubes can be employed for the successful design of platforms for immobilization of colloidal gold-antibodies suitable to be used as rapid analytical tools with potential application in the diagnosis of MP. Single-walled carbon nanotubes have a large surface area to volume ratio which makes them immobilize more colloidal gold-antibody conjugations to increase the sensitivity of the strip. Moreover, this method presents high specificity in detecting MP, no cross-reactions with other clinical pathogens.

The detection limit of SWCNT/CGIC assay (1 × 102 copies/mL) for MP was comparable to that of the Asahi company rapid antigen kit, which demonstrated sensitivities of 8.3 × 104 copies/mL25. In clinical test, we used commercial real-time PCR assay as a control method, targeting the P1 gene of MP. We applied the newly developed SWCNT/CGIC assay to the 137 specimens from children with pneumonia. 70(51.1%) specimens were positive for MP. When compared with real-time PCR, the specificity and sensitivity of the SWCNT/CGIC assay were 100% and 72.2%, respectively. The symptoms in all MP positive children were improved after treatment with azithromycin.

Reliable, rapid, and easy-toperform tests for the diagnosis of MP infections are helpful in guiding azithromycin usage and preventing further selection of macrolide-resistant MP.

In conclusion, we have successfully developed a new immunochromatographic strip for the rapid detection of the MP antigen using colloidal gold coupled with monoclonal antibody/single-walled carbon nanotubes, with high sensitivity and specificity. The new method is, therefore, a ideal and rapid determination method for detection of MP. The colloidal gold probe, colloidal gold coupled with monoclonal antibody/single-walled carbon nanotubes, we developed in this study can easily be extended for detecting other bacterial cells in real samples with high accuracy and sensitivity.

Methods

Materials

Chloroauric acid (HAuCl4·3H2O) and sodium citrate were purchased from the company of Sigma (USA). Bovine serum albumin (BSA) and goat anti-mouse IgG were purchased from DAKO (DK). High-flow nitrocellulose membrane, glass fiber, and absorption pad were purchased from Millipore (Bedford, MA). The mouse momoclonal antibodies against MP (named P-Ab1501 and P-Ab1502) were prepared by Benxi TestJet Biotechnologies. Bovine serum albumin (BSA) and goat anti-mouse IgG were purchased from Sigma (USA). Single-walled nanotubes were purchased from Beijing DK Daoking Technology Co.Standard M. pneumoniae FH (ATCC 15531) and M129 (ATCC 29342) strains were purchased from ATCC. Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus, Escherichia coli, Klebsiella Pneumoniae, Pseudomonas aeruginosa, Enterobacter cloacae, Staphylococcus epidermidis, Acinetobacter baumannii, Chlamydia pneumoniae, adenovirus, respiratory syncytial virus, parainfluenza virus, influenza virus, human cytomegalovirus, human metapneumovirus and enteroviruses were provided by Benxi TestJet Biotechnologies(China). All other chemicals used in the present study were analytically pure.


Clinical specimens

From Dec 1,2016 to Jan 31,2017, 137 children were enrolled in this study. The inclusion criteria were: (1) 3 <age< 14 years (56 females and 81 males); (2) patient visiting the pediatric respiratory depatment of The First Hospital of Jilin University; (3) primary diagnosis as pneumonia according to known guidelines(China). During 3 months, 137 specimens were collected. Each specimen was mixed with 1.0 ml sample buffer and stored at −70 °C; 0.5 ml of the mixture was used for real-time PCR and 0.5 ml in the SWCNT/CGIC assay.

The study was performed in accordance with the Declaration of Helsinki and approved by the Medical Ethics Committee of The First Hospital of Jilin University. All patients provided informed consent.


Synthesis and characterization of colloidal gold

In brief, the pH of the colloidal gold solution was adjusted to pH around 9.0 by adding 0.2 mol/L K2CO3 before the mouse monoclonal antibodies (named P-Ab1502,against M. Pneumoniae, which target the M. pneumoniae P1 antigen,were prepared by Benxi TestJet Biotechnology Co.) were added. Ten mL of colloidal gold was mixed with 200 μL of 0.5 mg/mL antibody, with shaking at intervals for 30 min.Then, another 1000 μL of 5% BSA was added, with shaking at intervals for 30 min. The dispersion of SWCNT (10 mg, DKnano, China) in pure water (100 mL) by ultrasonication for 5 min in presence of Tween20 (0.1 mL). The solution of Colloidal gold/IgGs was mixed with 50 μL SWCNT, with shaking at intervals for 30 min. The mixture was centrifuged at 6275 × g for 30 min at 4 °C. The pellet (SWCNT-colloidal gold-labeled antibody conjugation) was re-suspended with 5000 μL of the suspension buffer (0.01 mol/L pH 8.5 Tris-HCl, 25% sucrose, 2.5% BSA, 1.5%Tween-20, 0.25%PEG20000, 0.20%sodium caseinate). The mixture was centrifuged at 6275 × g for another 30 min at 4 °C, and the pellet was re-suspended in 240 μL of suspension buffer. SWCNT-colloidal gold-labeled antibody conjugation was jetted onto glass fiber and dried at 37 °C for 4 h.

The antibody against MP (P-Ab1501 antibody) was diluted to 1.5 mg/mL with 0.01 mol/L phosphate-buffered (PB; pH7.4). The diluted antibody (Test line, T line) and goat anti-mouse antibody (Control line, C line) were transferred onto a nitrocellulose membrane, which was then dried for 2 h at 37 °C.

The SWCNT/CGIC strip was composed of a sample pad, a conjugate pad, an immobilized nitrocellulose membrane, and an absorbent pad.

Colloidal gold particles were examined by a transmission electron microscope (TEM) performed on a JEM-2100 (JEOL, Japan) and operated at an acceleration voltage of 200 kV.


Real-time PCR for MP detection

For real-time PCR, 0.5 ml of the mixture was centrifuged for 5 min at 12000 rpm/min. The cell pellets were resuspended in 50 μL lysis buffer (Da An Gene Co., Ltd., China); 4 μL lysate served as template in real-time PCR amplification based on the TaqMan probe PCR kit (Da An Gene Co., Ltd., China) according to the manufacturer’s instructions. Real-time PCR was carried out on an ABI 7500 instrument for 3 min at 95 °C, followed by 40 two-step cycles (15 s at 95 °Cand 45 s at 55 °C).


MP serology analysis

Diagnostic Kit for Measurement of Antibodies to Mycoplasma pneumoniae (Passive Particle Agglutination, PPA)(SERODIA-MYCO II, Japan) was used to dectect the IgM antibodies. The plates were shaken for 30 s and then covered and left undisturbed on a level surface at room temperature for 3 hours. Results were considered positive at 1/80 titer or more.


SWCNT/CGIC assay for MP detection

To perform the SWCNT/CGIC assay, 80 μL (about 2 drops) of the mixture was added into a sample well for 10–15 minutes. Samples with positive control and test lines were determined as MP positive; no Control line on the plate indicated an invalid test.


Statistical analysis

The results were expressed as mean values with their corresponding standard errors. One-way analysis of variance (ANOVA) with least significant difference test (LSD) was used to compare experimental groups. A calculated P < 0.05 was considered statistically significant. All analyses were performed by SPSS for Windows Software Version 17.0.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Zhang, Y. et al. Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children.Sci Rep. 6, 37037 (2016).

  2. 2.

    Waites, K. B. & Talkington, D. F. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 17, 697–728 (2004).

  3. 3.

    Atkinson, T. P., Balish, M. F. & Waites, K. B. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 32, 956–973 (2008).

  4. 4.

    Cunha, B. A. Theatypical pneumonias: clinical diagnosis and importance. Clin Microbiol Infect 12, 12–24 (2016).

  5. 5.

    Principi, N. & Esposito, S. Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection. J Antimicrob Chemother 68, 506–511 (2013).

  6. 6.

    Ozaki, T. et al. Utility of a rapid diagnosis kit for Mycoplasma pneumoniae pneumonia in children, and the antimicrobial susceptibility of the isolates. J Infect Chemother 13, 204–207 (2007).

  7. 7.

    Kishaba, T. Community-acquired pneumonia caused by Mycoplasma pneumoniae: How physical and radiological examination contribute to successful diagnosis.Front Med (Lausanne) 3, 28 (2016).

  8. 8.

    Busson, L. et al. Evaluation of 10 serological assays for diagnosing Mycoplasma pneumoniae infection. Diagn Microbiol Infect Dis 76, 133–137 (2013).

  9. 9.

    Schmitt, B. H., Sloan, L. M. & Patel, R. Real-time PCR detection of Mycoplasma pneumoniae in respiratory specimens. Diagn Microbiol Infect Dis 77, 202–205 (2013).

  10. 10.

    Ojeda, I. et al. Grafted-double walled carbon nanotubes as electrochemical platforms for immobilization of antibodies using a metallic-complex chelating polymer: Application to the determination of adiponectin cytokine in serum. Biosens Bioelectron. 74, 24–29 (2015).

  11. 11.

    Zhang, X. et al. A novel electrochemical immunosensor for highly sensitive detection of aflatoxin B1 in corn using single-walled carbon nanotubes/chitosan. Food Chem. 192, 197–202 (2016).

  12. 12.

    Sharma, A., Hong, S., Singh, R. & Jang, J. Single-walled carbon nanotube based transparent immunosensor for detection of a prostate cancer biomarker osteopontin. Anal Chim Acta. 869, 68–73 (2015).

  13. 13.

    Yamada, K. et al. Single walled carbon nanotube-based junction biosensor for detection of Escherichia coli. PLoS One. 9, e105767 (2014).

  14. 14.

    Bartlett, J. G. & Mundy, L. M. Community-acquired pneumonia. N Engl J Med. 333, 1618–1624 (1995).

  15. 15.

    Yan, Y., Wei, Y., Jiang, W. & Hao, C. The clinical characteristics of corticosteroid-resistant refractory Mycoplasma Pneumoniae pneumonia in children. Sci Rep. 23, 6:39929 (2016).

  16. 16.

    Youn, Y. S. et al. Early Additional Immune-Modulators for Mycoplasma pneumoniae Pneumonia in Children: An Observation Study. Infect Chemother. 46, 239–247 (2014).

  17. 17.

    Thurman, K. A. et al. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 48, 1244–1249 (2009).

  18. 18.

    Parrott, G. L., Kinjo, T. & Fujita, J. A Compendium for Mycoplasma pneumoniae. Front Microbiol. 12(7), 513 (2016).

  19. 19.

    Daxboeck, F., Krause, R. & Wenisch, C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect. 9(4), 263–273 (2003).

  20. 20.

    Meng, K. et al. Development of colloidal gold-based immunochromatographic assay for rapid detection of Mycoplasma suis in porcine plasma. Biosens Bioelectron. 55, 396–399 (2014).

  21. 21.

    Nakane, D., Adan-Kubo, J., Kenri, T. & Miyata, M. Isolation and characterization of P1 adhesin, a leg protein of the gliding bacterium Mycoplasma pneumoniae. J Bacteriol. 193(3), 715–722 (2011).

  22. 22.

    Kenri, T. et al. Identification of a new variable sequence in the P1 cytadhesin gene of Mycoplasma pneumoniae: evidence for the generation of antigenic variation by DNA recombination between repetitive sequences. Infect Immun. 67(9), 4557–4562 (1999).

  23. 23.

    Xiao, J. et al. Detection of Mycoplasma pneumoniae P1 subtype variations by denaturing gradient gel electrophoresis.Diagn Microbiol Infect Dis. 78(1), 24–28 (2014).

  24. 24.

    Medjo, B. et al. Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis. Ital J Pediatr. 40, 104 (2014).

  25. 25.

    Miyashita, N. et al. Diagnostic sensitivity of a rapid antigen test for the detection of Mycoplasma pneumoniae: Comparison with real-time PCR. J Infect Chemother. 21, 473–475 (2015).

Download references

Acknowledgements

The study was supported by National High Tech Research and Development Fund (2014AA020901), Liaoning Scientific Research Project(201610163L32) and The Sientific and Technological Program in Liaoning Province(201602700).

Author information

Affiliations

  1. Institute of Life Science and Bio-pharmaceutics, Shenyang Pharmaceutical University, Shenyang, 110016, China

    • Ming Song
    • , Sulan Cai
    • , Wei Xu
    •  & Weizhuo Xu
  2. Shenyang Entry-Exit Inspection and Quarantine Bureau Technology Center, Shenyang, 110016, China

    • Ying Zhang
  3. Haihua College, Liaoning Normal University, Shenyang, 110167, China

    • Shi Li
  4. Benxi TestJet Biotechnology Co., Benxi, 117004, China

    • Chunsheng Zhang
    • , Mingming Tao
    •  & Zhuquan Jiang
  5. The First Hospital of Jilin University, Changchun, 130021, China

    • Ying Tang

Authors

  1. Search for Ming Song in:

  2. Search for Ying Zhang in:

  3. Search for Shi Li in:

  4. Search for Chunsheng Zhang in:

  5. Search for Mingming Tao in:

  6. Search for Ying Tang in:

  7. Search for Zhuquan Jiang in:

  8. Search for Sulan Cai in:

  9. Search for Wei Xu in:

  10. Search for Weizhuo Xu in:

Contributions

M.S., Y.Z., Y.T. and W.Z.X. designed research; M.S., C.Z. and M.T. performed experiments; S.L., M.T., Z.J., S.C. and W.X. analyzed data; M.S.and W.Z.X. wrote the manuscript; All authors reviewed and approved the manuscript.

Competing Interests

The authors declare that they have no competing interests.

Corresponding author

Correspondence to Weizhuo Xu.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/s41598-017-16652-3

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.